Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 30, Issue 8, 2015, Pages 1315-1321

  Yasutake, Junichi ^a,b   Suzuki, Yusuke ^a   Suzuki, Hitoshi ^a   Hiura, Naoko ^a,b   Yanagawa, Hiroyuki ^a   Makita, Yuko ^a   Kaneko, Etsuji ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

ELISA; galactose deficient IgA1; helix aspersa agglutinin (HAA); IgA nephropathy; immunofluorescence; monoclonal antibody

Indexed keywords

AGGLUTININ; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; LECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KM55; PEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; DEFICIENCY; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, IGA; HUMAN; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

AGGLUTININS; ANIMALS; ANTIBODIES, MONOCLONAL; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY GLOMERULUS; LECTINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84939620115     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv221     Document Type: Article

References (22)

1. McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2011; 26: 414-430
2. Suzuki Y, Matsuzaki K, SuzukiHet al. Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol 2014; 18: 481-486
3. Moore JS, Kulhavy R, Tomana M et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 2007; 44: 2598-2604
4. Suzuki H, Moldoveanu Z, Hall S et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629-639
5. Suzuki H, Kiryluk K, Novak J et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol 2011; 22: 1795-1803
6. Berthoux F, Suzuki H, Thibaudin L et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23: 1579-1587
7. Moldoveanu Z,Wyatt RJ, Lee JY et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148-1154
8. Gomes MM, Suzuki H, Brooks MT et al. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 byN-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry 2010; 49: 5671-5682
9. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509-516
10. Laitinen L, Juusela H, Virtanen I. Binding of the blood group-reactive lectins to human adult kidney specimens. Anat Rec 1990; 226: 10-17
11. Suzuki H, Fan R, Zhang Z et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668-1677
12. Suzuki H, Raska M, Yamada K et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem 2014; 289: 5330-5339
13. Suzuki Y, Matsuzaki K, Suzuki H et al. Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol 2014; 18: 770-777
14. Yanagawa H, Suzuki H, Suzuki Y et al. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PLoS One 2014; 23: e98081
15. Renfrow MB, Cooper HJ, Tomana M et al. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 2005; 280: 19136-19145
16. Takahashi K,Wall SB, SuzukiHet al. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics 2010; 9: 2545-2557
17. Takahashi K, Smith AD, Poulsen K et al. Naturally occurring structural isomers in serum IgA1 O-glycosylation. J Proteome Res 2012; 11: 692-702
18. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973
19. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
20. Nakata J, Suzuki Y, Suzuki H et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One 2014; 9: e89707
21. Novak J, Raskova Kafkova L, Suzuki H et al. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrol Dial Transplant 2011; 26: 3451-3457
22. Coppo R, Fonsato V, Balegno S et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int 2010; 77: 417-427